Inlyta Dosage

Generic name: axitinib
Drug classes: Multikinase inhibitors, VEGF/VEGFR inhibitors

Medically reviewed by  A Ras MD.

Recommended Adult Dosing

Dosage forms:  TAB: 1 mg, 5 mg

Renal cell CA, advanced

[first-line tx, combo w/ avelumab]

Dose: 5-10 mg PO q12h; Start: 5 mg PO q12h for at least 2wk, if normotensive w/o receiving antihypertensive, and no Grade >2 ADR, may incr. to 7 mg PO q12h, then 10 mg PO q12h no more frequently than q2wk; Info: do not cut/crush/chew tab

[first-line tx, combo w/ pembrolizumab]

Dose: 5-10 mg PO q12h; Start: 5 mg PO q12h for at least 6wk, if normotensive w/o receiving antihypertensive, and no Grade >2 ADR, may incr. to 7 mg PO q12h, then 10 mg PO q12h no more frequently than q6wk; Info: do not cut/crush/chew tab

[2nd-line tx, monotherapy]

Dose: 5-10 mg PO q12h; Start: 5 mg PO q12h for at least 2wk, if normotensive w/o receiving antihypertensive, and no Grade >2 ADR, may incr. to 7 mg PO q12h, then 10 mg PO q12h no more frequently than q2wk; Info: do not cut/crush/chew tab

Renal dosing

CrCl >15: no adjustment; CrCl <15: not defined, caution advised

HD/PD: not defined

Hepatic dosing

[adjust dose amount]

Child-Pugh Class B: decr. start dose by approx. 50%; Child-Pugh Class C: not defined

SRC: NLM .